Drug Hypersensitivity, An Issue of Immunology and Allergy Clinics of North America

Recognizing Drug Hypersensitivity in Pigmented Skin<br>Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management<br>Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E– Mediated Drug Hypersensitivity<br>Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models<br>Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions<br>Telemedicine in Drug Hypersensitivity<br>Pharmacogenomics of Drug Hypersensitivity: Technology and Translation<br>Advances in the Pathomechanisms of Delayed Drug Hypersensitivity<br>A Risk-Based Approach to Penicillin Allergy<br>Allergy to Radiocontrast Dye<br>The Who, What, Where, When, Why, and How of Drug Desensitization<br>Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity<br>Pediatric Drug Allergy<br>The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review